Wells Fargo’s Oruka Therapeutics ORKA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.97M Sell
23,642
-28,282
-54% -$2.66M ﹤0.01% 3323
2026
Q2
$4.94M Buy
51,924
+37,093
+250% +$2.47M ﹤0.01% 2859
2026
Q1
$727K Sell
14,831
-28,430
-66% -$988K ﹤0.01% 3935
2025
Q4
$1.31M Buy
43,261
+22,405
+107% +$624K ﹤0.01% 3758
2025
Q3
$401K Buy
20,856
+3,401
+19% +$50.4K ﹤0.01% 4459
2025
Q2
$196K Buy
+17,455
New +$182K ﹤0.01% 4788
2024
Q2
– Sell
-7
Closed -$279 – 6855
2024
Q1
$141 Hold
7
– – ﹤0.01% 6583
2023
Q4
$134 Buy
7
+1
+17% +$22 ﹤0.01% 6699
2023
Q3
$151 Sell
6
-3
-33% -$73 ﹤0.01% 6649
2023
Q2
$211 Buy
9
+1
+13% +$25 ﹤0.01% 6687
2023
Q1
$199 Hold
8
– – ﹤0.01% 6773
2022
Q4
$232 Hold
8
– – ﹤0.01% 6583
2022
Q3
$0 Hold
8
– – ﹤0.01% 7522
2022
Q2
$0 Buy
8
+1
+14% +$28 ﹤0.01% 7647
2022
Q1
$0 Hold
7
– – ﹤0.01% 7978
2021
Q4
$0 Hold
7
– – ﹤0.01% 7930
2021
Q3
$0 Sell
7
-6
-46% -$222 ﹤0.01% 7633
2021
Q2
$0 Buy
13
+8
+160% +$334 ﹤0.01% 7567
2021
Q1
$0 Hold
5
– – ﹤0.01% 7492
2020
Q4
$0 Buy
5
+2
+67% +$100 ﹤0.01% 7128
2020
Q3
$0 Buy
3
+2
+200% +$141 ﹤0.01% 7023
2020
Q2
$0 Hold
1
– – ﹤0.01% 6936
2020
Q1
$0 Buy
+1
New +$54 ﹤0.01% 6924
2016
Q3
– Sell
-1
Closed – – 6379
2016
Q2
$0 Hold
1
– – ﹤0.01% 6371
2016
Q1
$0 Hold
1
– – ﹤0.01% 6483
2015
Q4
$1K Hold
1
– – ﹤0.01% 6120
2015
Q3
$1K Hold
1
– – ﹤0.01% 6088
2015
Q2
$1K Buy
+1
New +$1.32K ﹤0.01% 6267
2015
Q1
– Hold
0
– – – 6402
2014
Q4
– Hold
0
– – – 6457
2014
Q3
– Hold
0
– – – 6382
2014
Q2
– Hold
0
– – – 6325
2014
Q1
– Hold
0
– – – 6113
2013
Q4
– Hold
0
– – – 5962
2013
Q3
– Hold
0
– – – 5877
2013
Q2
– Hold
0
– – – 5719

Other funds holding ORKA

Wells Fargo's ORKA Position: Q3 2026 in Review

Wells Fargo reduced its Oruka Therapeutics (ORKA) stake by 54% in Q3 2026, selling an estimated $2.66M and leaving 23,642 shares worth $1.97M. The position accounts for ﹤0.01% of the portfolio, ranked #3323.

Wells Fargo first reported a position in ORKA in Q2 2015 and has held it in 28 quarters since. The position peaked at $4.94M in Q2 2026. 259 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

  • Wells Fargo held 23,642 shares of Oruka Therapeutics worth $1.97M as of Q3 2026.
  • Wells Fargo sold 28,282 Oruka Therapeutics shares in Q3 2026, an estimated $2.66M.
  • Oruka Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #3323 holding.
  • Wells Fargo first reported a position in Oruka Therapeutics in Q2 2015 and has held it in 28 quarters since.
  • Wells Fargo's Oruka Therapeutics position peaked at $4.94M in Q2 2026.
  • 259 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.